Review of Epidemiology, Diagnosis, and Treatment of Osteosarcopenia in Korea
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Sarcopenia was listed in the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) as M62.84, on October 1, 2016. Sarcopenia is primarily associated with metabolic diseases, such as diabetes, obesity, and cachexia, as well as chronic renal failure, congestive heart failure, and chronic obstructive pulmonary disease. Sarcopenia is also significantly associated with osteoporosis in elderly populations and the combined disease is defined as osteosarcopenia. Several studies have confirmed that sarcopenia and osteoporosis (osteosarcopenia) share common risk factors and biological pathways. Osteosarcopenia is associated with significant physical disability, representing a significant threat to the loss of independence in later life. However, the pathophysiology and diagnosis of osteosarcopenia are not fully defined. Additionally, pharmacologic and hormonal treatments for sarcopenia are undergoing clinical trials. This review summarizes the epidemiology, pathophysiology, diagnosis, and treatment of osteosarcopenia, and includes Korean data.
Abstract
Sarcopenia was listed in the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) as M62.84, on October 1, 2016. Sarcopenia is primarily associated with metabolic diseases, such as diabetes, obesity, and cachexia, as well as chronic renal failure, congestive heart failure, and chronic obstructive pulmonary disease. Sarcopenia is also significantly associated with osteoporosis in elderly populations and the combined disease is defined as osteosarcopenia. Several studies have confirmed that sarcopenia and osteoporosis (osteosarcopenia) share common risk factors and biological pathways. Osteosarcopenia is associated with significant physical disability, representing a significant threat to the loss of independence in later life. However, the pathophysiology and diagnosis of osteosarcopenia are not fully defined. Additionally, pharmacologic and hormonal treatments for sarcopenia are undergoing clinical trials. This review summarizes the epidemiology, pathophysiology, diagnosis, and treatment of osteosarcopenia, and includes Korean data.
참고문헌 (43)
- Jae Won Lim, "The changing trends in live birth statistics in Korea, 1970 to 2010", Clinical and Experimental Pediatrics, 54(11), pp.429~435 (2011), 대한소아청소년과학회
- Ha YC, "Current trends and future projections of hip fracture in South Korea using nationwide claims data", Osteoporos Int, 27, pp.2603~2609 (2016)[DOI]
- Lexell J, "Human aging, muscle mass, and fiber type composition", J Gerontol A Biol Sci Med Sci, 50(Spec No), pp.11~16 (1995)
- Zhai G, "Natural history and risk factors for bone loss in postmenopausal Caucasian women: a 15-year follow-up population-based study", Osteoporos Int, 19, pp.1211~1217 (2008)[DOI]
- Choi YJ, "The prevalence of osteoporosis in Korean adults aged 50 years or older and the higher diagnosis rates in women who were beneficiaries of a national screening program: the Korea National Health and Nutrition Examination Survey 2008-2009", J Bone Miner Res, 27, pp.1879~1886 (2012)[DOI]
- 권유준, "Prevalence of Osteoporosis and Effectiveness of Screening Test Using Ultrasound Bone Densitometry and Education in a Community-Dwelling Population", Journal of Korean Medical Science, 32(2), pp.352~356 (2017), 대한의학회
- Park C, "The incidence and residual lifetime risk of osteoporosis-related fractures in Korea", J Bone Miner Metab, 29, pp.744~751 (2011)[DOI]
- Short KR, "Age and aerobic exercise training effects on whole body and muscle protein metabolism", Am J Physiol Endocrinol Metab, 286, pp.E92~E101 (2004)[DOI]
- von Haehling S, "From muscle wasting to sarcopenia and myopenia: update 2012", J Cachexia Sarcopenia Muscle, 3, pp.213~217 (2012)[DOI]
- 김경민, "Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia", The Korean Journal of Internal Medicine, 31(4), pp.643~650 (2016), 대한내과학회[DOI]
- 권형준, "Prevalence of Sarcopenia in the Korean Woman Based on the Korean National Health and Nutritional Examination Surveys", 대한골대사학회지, 23(1), pp.23~26 (2016), 대한골대사학회[DOI]
- Hida T, "High prevalence of sarcopenia and reduced leg muscle mass in Japanese patients immediately after a hip fracture", Geriatr Gerontol Int, 13, pp.413~420 (2013)[DOI]
- Di Monaco M, "Sarcopenia is more prevalent in men than in women after hip fracture: a cross-sectional study of 591 inpatients", Arch Gerontol Geriatr, 55, pp.e48~e52 (2012)[DOI]
- 유준일, "High Prevalence of Sarcopenia in Korean Patients after Hip Fracture: A Case-Control Study", Journal of Korean Medical Science, 31(9), pp.1479~1484 (2016), 대한의학회
- 유준일, "Osteosarcopenia in Patients with Hip Fracture Is Related with High Mortality", Journal of Korean Medical Science, 33(4), pp.37~45 (2018), 대한의학회
- Huo YR, "Phenotype of osteosarcopenia in older individuals with a history of falling", J Am Med Dir Assoc, 16, pp.290~295 (2015)[DOI]
- Wang YJ, "Sarco-osteoporosis: prevalence and association with frailty in Chinese communitydwelling older adults", Int J Endocrinol, 2015, pp.482940~ (2015)
- Drey M, "Osteosarcopenia is more than sarcopenia and osteopenia alone", Aging Clin Exp Res, 28, pp.895~899 (2016)[DOI]
- Goodman CA, "Bone and skeletal muscle: key players in mechanotransduction and potential overlapping mechanisms", Bone, 80, pp.24~36 (2015)[DOI]
- Olsen BR, "Bone development", Annu Rev Cell Dev Biol, 16, pp.191~220 (2000)[DOI]
- Garatachea N, "Genes and the ageing muscle: a review on genetic association studies", Age (Dordr), 35, pp.207~233 (2013)[DOI]
- Tan LJ, "Molecular genetic studies of gene identification for sarcopenia", Hum Genet, 131, pp.1~31 (2012)[DOI]
- Cho J, "ACTN3 gene and susceptibility to sarcopenia and osteoporotic status in older Korean adults", Biomed Res Int, 2017, pp.4239648~ (2017)
- Gonzalez-Mercado A, "Association analysis of vitamin D receptor gene polymorphisms and bone mineral density in postmenopausal Mexican-Mestizo women", Genet Mol Res, 12, pp.2755~2763 (2013)[DOI]
- Karasik D, "Genetics of the musculoskeletal system: a pleiotropic approach", J Bone Miner Res, 23, pp.788~802 (2008)[DOI]
- Reed T, "Genetic influences and grip strength norms in the NHLBI twin study males aged 59-69", Ann Hum Biol, 18, pp.425~432 (1991)[DOI]
- Arden NK, "Genetic influences on muscle strength, lean body mass, and bone mineral density: a twin study", J Bone Miner Res, 12, pp.2076~2081 (1997)[DOI]
- 강선영, "Association between Sarcopenic Obesity and Metabolic Syndrome in Postmenopausal Women: A Cross-sectional Study Based on the Korean National Health and Nutritional Examination Surveys from 2008 to 2011", 대한골대사학회지, 24(1), pp.9~14 (2017), 대한골대사학회[DOI]
- Hiroshi Kaji, "Interaction between Muscle and Bone", 대한골대사학회지, 21(1), pp.29~40 (2014), 대한골대사학회
- Kim HY, "Development of a Korean fracture risk score (KFRS) for predicting osteoporotic fracture risk: Analysis of data from the Korean national health insurance service", PLoS One, 11, pp.e0158918~ (2016)[DOI]
- Lee WJ, "Comparisons of sarcopenia defined by IWGS and EWGSOP criteria among older people: results from the I-Lan longitudinal aging study", J Am Med Dir Assoc, 14, pp.528.e1~528.e7 (2013)
- Chen LK, "Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia", J Am Med Dir Assoc, 15, pp.95~101 (2014)[DOI]
- Yoshimura N, "Is osteoporosis a predictor for future sarcopenia or vice versa? Four-year observations between the second and third ROAD study surveys", Osteoporos Int, 28, pp.189~199 (2017)[DOI]
- Buehring B, "Effect of including historical height and radius BMD measurement on sarco-osteoporosis prevalence", J Cachexia Sarcopenia Muscle, 4, pp.47~54 (2013)[DOI]
- Bruyere O, "Vitamin D and osteosarcopenia: an update from epidemiological studies", Curr Opin Clin Nutr Metab Care, 20, pp.498~503 (2017)
- Sakuma K, "Recent advances in pharmacological, hormonal, and nutritional intervention for sarcopenia", Pflugers Arch, 470, pp.449~460 (2018)[DOI]
- Kanis JA, "European guidance for the diagnosis and management of osteoporosis in postmenopausal women", Osteoporos Int, 24, pp.23~57 (2013)[DOI]
- Deutz NE, "Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group", Clin Nutr, 33, pp.929~936 (2014)[DOI]
- Bauer J, "Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group", J Am Med Dir Assoc, 14, pp.542~559 (2013)[DOI]
- Kim CO, "Preventive effect of protein-energy supplementation on the functional decline of frail older adults with low socioeconomic status: a community-based randomized controlled study", J Gerontol A Biol Sci Med Sci, 68, pp.309~316 (2013)[DOI]
- Peterson MD, "Resistance exercise for muscular strength in older adults: a meta-analysis", Ageing Res Rev, 9, pp.226~237 (2010)[DOI]
- Law TD, "Resistance exercise to prevent and manage sarcopenia and dynapenia", Annu Rev Gerontol Geriatr, 36, pp.205~228 (2016)[DOI]
- 김광일, "Evidence-based guidelines for fall prevention in Korea", The Korean Journal of Internal Medicine, 32(1), pp.199~212 (2017), 대한내과학회[DOI]
